| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Beone Medicines AG's insiders have reduced their positions by a net 31,028 shares worth roughly $11.3M. In the past 30 days, 0 insiders bought and 1 sold.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 397.9K | $141.25M | - | |
| Dir | 161.6K | $57.35M | - | |
| Other | 99.6K | $35.37M | - | |
| Dir | 83.7K | $29.72M | - | |
| Dir | 73.2K | $25.97M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 1, 2023 | Julia Aijun Wang54 | Chief Financial Officer | Sell | 343 | $240.21 | $82,391.89 | -100% | -3.2% | -29.8% | |
| Jan 12, 2023 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sell | 5,000 | $260.52 | $1,302,584.67 | -100% | -3.2% | -33.4% | |
| Jan 11, 2023 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sell | 5,000 | $251.36 | $1,256,798.90 | -100% | -0.9% | -31.2% | |
| Jan 10, 2023 | John Oyler58 | Chief Executive Officer | Sell | 20,391 | $248.51 | $5,067,448.97 | -100% | -6.0% | -30.0% | |
| Dec 29, 2022 | John Oyler58 | Chief Executive Officer | Sell | 9,609 | $224.43 | $2,156,571.66 | -100% | -0.9% | -19.4% | |
| Dec 13, 2022 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sell | 3,013 | $211.33 | $636,722.95 | -100% | +6.8% | -11.9% | |
| Nov 15, 2022 | John Oyler58 | Chief Executive Officer | Sell | 29,928 | $206.84 | $6,190,333.83 | -100% | +18.0% | -5.4% | |
| Nov 15, 2022 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sell | 1,987 | $210.14 | $417,541.42 | -100% | +18.0% | -5.4% | |
| Sep 21, 2022 | John Oyler58 | Chief Executive Officer | Sell | 50,000 | $152.13 | $7,606,556.24 | -100% | +40.2% | +26.2% | |
| Aug 8, 2022 | Xiaodong Wang58 | Director, Chair, Scientific Advisory Brd | Sell | 16,060 | $196.65 | $3,158,121.32 | -100% | -4.7% | -5.3% |